Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 15 studies | 25% ± 7% | |
astrocyte | 12 studies | 39% ± 22% | |
endothelial cell | 11 studies | 21% ± 4% | |
type II pneumocyte | 10 studies | 46% ± 15% | |
glutamatergic neuron | 6 studies | 37% ± 19% | |
epithelial cell | 6 studies | 27% ± 10% | |
adipocyte | 6 studies | 23% ± 4% | |
oligodendrocyte | 6 studies | 28% ± 15% | |
hepatocyte | 5 studies | 58% ± 28% | |
microglial cell | 5 studies | 23% ± 5% | |
macrophage | 5 studies | 23% ± 7% | |
oligodendrocyte precursor cell | 5 studies | 27% ± 9% | |
mucus secreting cell | 4 studies | 55% ± 30% | |
retinal cone cell | 4 studies | 29% ± 12% | |
retinal rod cell | 4 studies | 30% ± 10% | |
type I pneumocyte | 4 studies | 22% ± 9% | |
club cell | 4 studies | 22% ± 5% | |
endothelial cell of lymphatic vessel | 4 studies | 21% ± 4% | |
fibroblast | 4 studies | 26% ± 7% | |
secretory cell | 4 studies | 21% ± 4% | |
cholangiocyte | 3 studies | 52% ± 26% | |
duct epithelial cell | 3 studies | 32% ± 16% | |
cardiac muscle cell | 3 studies | 19% ± 1% | |
GABAergic neuron | 3 studies | 55% ± 8% | |
ependymal cell | 3 studies | 34% ± 16% | |
respiratory goblet cell | 3 studies | 28% ± 11% | |
basal cell | 3 studies | 33% ± 11% | |
granule cell | 3 studies | 27% ± 8% | |
interneuron | 3 studies | 45% ± 20% | |
neuron | 3 studies | 44% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 619.22 | 245 / 245 | 99% | 3.70 | 499 / 502 |
pancreas | 99% | 560.59 | 326 / 328 | 98% | 2.82 | 175 / 178 |
thymus | 100% | 508.17 | 652 / 653 | 98% | 3.10 | 592 / 605 |
liver | 100% | 2814.10 | 226 / 226 | 97% | 19.02 | 394 / 406 |
breast | 100% | 468.09 | 459 / 459 | 97% | 2.99 | 1081 / 1118 |
bladder | 100% | 640.14 | 21 / 21 | 95% | 4.76 | 480 / 504 |
kidney | 100% | 840.90 | 89 / 89 | 95% | 6.28 | 856 / 901 |
lung | 99% | 499.39 | 573 / 578 | 93% | 3.04 | 1077 / 1155 |
uterus | 100% | 543.70 | 170 / 170 | 92% | 2.80 | 424 / 459 |
ovary | 100% | 456.46 | 180 / 180 | 92% | 2.29 | 396 / 430 |
intestine | 100% | 443.05 | 966 / 966 | 91% | 8.37 | 481 / 527 |
brain | 99% | 496.50 | 2620 / 2642 | 92% | 2.21 | 648 / 705 |
skin | 100% | 533.13 | 1804 / 1809 | 89% | 2.47 | 422 / 472 |
stomach | 100% | 401.68 | 359 / 359 | 82% | 7.23 | 234 / 286 |
esophagus | 100% | 371.78 | 1441 / 1445 | 73% | 1.58 | 133 / 183 |
adrenal gland | 100% | 1158.63 | 258 / 258 | 63% | 1.20 | 144 / 230 |
muscle | 100% | 1661.07 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.61 | 1 / 1 |
spleen | 100% | 289.61 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 339.80 | 1196 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 400.42 | 1323 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 450.44 | 821 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 1.91 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 86% | 2.06 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 1.72 | 25 / 29 |
peripheral blood | 81% | 256.10 | 755 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070050 | Biological process | neuron cellular homeostasis |
GO_0046835 | Biological process | carbohydrate phosphorylation |
GO_0019321 | Biological process | pentose metabolic process |
GO_0005575 | Cellular component | cellular_component |
GO_0005737 | Cellular component | cytoplasm |
GO_0019150 | Molecular function | D-ribulokinase activity |
Gene name | FGGY |
Protein name | FGGY carbohydrate kinase domain-containing protein (D-ribulokinase FGGY) (EC 2.7.1.47) FGGY carbohydrate kinase domain containing |
Synonyms | |
Description | FUNCTION: Catalyzes ATP-dependent phosphorylation of D-ribulose at C-5 to form D-ribulose 5-phosphate. Postulated to function in a metabolite repair mechanism by preventing toxic accumulation of free D-ribulose formed by non-specific phosphatase activities. Alternatively, may play a role in regulating D-ribulose 5-phosphate recycling in the pentose phosphate pathway. Can phosphorylate ribitol with low efficiency. . |
Accessions | ENST00000634364.1 F2Z2V1 ENST00000371210.1 [Q96C11-6] ENST00000430447.5 ENST00000303721.12 [Q96C11-1] A0A0U1RQJ1 A0A0U1RQS3 ENST00000635156.1 [Q96C11-5] J3QKV9 ENST00000634399.1 A0A0U1RRB9 ENST00000635297.1 ENST00000371212.5 [Q96C11-5] A0A0U1RRI8 ENST00000634606.1 Q96C11 C9J015 A0A0U1RR53 ENST00000582567.1 ENST00000424725.2 ENST00000413489.5 ENST00000371218.8 [Q96C11-3] |